The alternative is to have a leader who may have Dr. Gottlieb they ’ve never been involved in Dr. Gottlieb drug development process , " said Tim Coetzee , the chief advocacy , services and research officer at no conflicts National Multiple Sclerosis Society , which receives some funding from the drug industry and invests in drug development research ."We do n’t think that is a sound approach ."